Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Haruhiko Kawaguchi"'
Autor:
Haruhiko Kawaguchi, Takuya Sakamoto, Terutsugu Koya, Misa Togi, Ippei Date, Asuka Watanabe, Kenichi Yoshida, Tomohisa Kato, Yuka Nakamura, Yasuhito Ishigaki, Shigetaka Shimodaira
Publikováno v:
Vaccines, Vol 9, Iss 5, p 533 (2021)
Dendritic cell (DC) vaccines for cancer immunotherapy have been actively developed to improve clinical efficacy. In our previous report, monocyte−derived DCs induced by interleukin (IL)−4 with a low−adherence dish (low−adherent IL-4−DCs: la
Externí odkaz:
https://doaj.org/article/1f2ade1aaeb540a1ace7a9902cbd65a8
Autor:
Ippei Date, Terutsugu Koya, Takuya Sakamoto, Misa Togi, Haruhiko Kawaguchi, Asuka Watanabe, Tomohisa Kato, Shigetaka Shimodaira
Publikováno v:
Vaccines, Vol 9, Iss 1, p 10 (2020)
Given the recent advancements of immune checkpoint inhibitors, there is considerable interest in cancer immunotherapy provided through dendritic cell (DC)-based vaccination. Although many studies have been conducted to determine the potency of DC vac
Externí odkaz:
https://doaj.org/article/65eecf27ca264985abb1b9f2c4d23e07
Autor:
Terutsugu Koya, Ippei Date, Haruhiko Kawaguchi, Asuka Watanabe, Takuya Sakamoto, Misa Togi, Tomohisa Kato, Kenichi Yoshida, Shunsuke Kojima, Ryu Yanagisawa, Shigeo Koido, Haruo Sugiyama, Shigetaka Shimodaira
Publikováno v:
Pharmaceutics, Vol 12, Iss 4, p 305 (2020)
With recent advances in cancer vaccination therapy targeting tumor-associated antigens (TAAs), dendritic cells (DCs) are considered to play a central role as a cell-based drug delivery system in the bioactive immune environment. Ex vivo generation of
Externí odkaz:
https://doaj.org/article/25691590c3fd4000a16699a6a1a4eb7f
Autor:
Misa Togi, Terutsugu Koya, Haruhiko Kawaguchi, Shigetaka Shimodaira, Asuka Watanabe, Takuya Sakamoto, Tomohisa Kato, Ippei Date
Publikováno v:
Vaccines
Volume 9
Issue 1
Vaccines, Vol 9, Iss 10, p 10 (2021)
Volume 9
Issue 1
Vaccines, Vol 9, Iss 10, p 10 (2021)
Given the recent advancements of immune checkpoint inhibitors, there is considerable interest in cancer immunotherapy provided through dendritic cell (DC)-based vaccination. Although many studies have been conducted to determine the potency of DC vac
Autor:
Asuka Watanabe, Takuya Sakamoto, Terutsugu Koya, Haruhiko Kawaguchi, Shigetaka Shimodaira, Tomohisa Kato, Misa Togi, Ippei Date, Kenichi Yoshida, Yuka Nakamura, Yasuhito Ishigaki
Publikováno v:
Vaccines, Vol 9, Iss 533, p 533 (2021)
Vaccines
Volume 9
Issue 5
Vaccines
Volume 9
Issue 5
Dendritic cell (DC) vaccines for cancer immunotherapy have been actively developed to improve clinical efficacy. In our previous report, monocyte−derived DCs induced by interleukin (IL)−4 with a low−adherence dish (low−adherent IL-4−DCs: la
Autor:
Nicolas Bakaher, Haruhiko Kawaguchi, Masataka Kajikawa, Nicolas Sierro, Nikolai V. Ivanov, Takashi Hashimoto, Tsubasa Shoji
Publikováno v:
Plant physiology. 174(2)
In tobacco (Nicotiana tabacum), nicotine is the predominant alkaloid. It is produced in the roots and accumulated mainly in the leaves. Jasmonates play a central signaling role in damage-induced nicotine formation. The genome sequence of tobacco prov
Publikováno v:
Japanese Journal of Cancer Research : Gann
Small cell lung cancer (SCLC) cell lines specifically express ganglioside GD2, and anti-GD2 monoclonal antibodies (mAbs) caused suppression of cell growth and induced apoptosis of SCLC cells with single use. Here, enhancement of the cytotoxic effects
Autor:
Hiroyoshi Maeda, Ryuzo Ueda, Shigemitsu Ninomiya, Shigeki Sato, Haruhiko Kawaguchi, Kenji Akita, Hiroyuki Achiwa, Yoshitaka Fujii, Takashi Niimi, Shigeki Shimizu, Hiroshi Inagaki, Yosuke Yamakawa, Tadaaki Eimoto
Publikováno v:
Japanese Journal of Cancer Research : Gann
p185(HER-2/neu), a tyrosine kinase receptor, is one of the target molecules for cancer therapy, and its expression may reduce the sensitivity of tumor cells to anti-cancer drugs. p21(CIP1/WAF1) is a cyclin-dependent kinase inhibitor, and its expressi
Autor:
Takashi Niimi, Toshiyuki Mori, Hiroyoshi Maeda, Nobuo Ogisu, Haruhiko Kawaguchi, Yoshiki Sugiura, Kenji Akita, Y. Yamada, Ryuzo Ueda, Shigeki Sato
Publikováno v:
Internal Medicine. 40:201-207
Objective Soluble HLA class I antigens (sHLAs) in human serum have been reported to be associated with allografts and autoimmune disease and could modify immunological reactions induced by membrane type HLAs. To investigate the clinical significance
Autor:
Takashi Niimi, Yoshiki Sugiura, Ryuzo Ueda, Haruhiko Kawaguchi, Hiroyoshi Maeda, Shigeki Sato, Shigeo Mori
Publikováno v:
Chest. 118:923-927
Study objectives: The etiology of sarcoidosis remainsunknown, but recently it was reported that human herpesvirus 8 (HHV-8)may be detected in sarcoid tissue in a high proportion of patients. This study was performed to determine whether HHV-8 is impl